COMMUNIQUÉS West-GlobeNewswire

Zomedica Announces Achievement of Therapeutic Development Milestones
12/12/2017
ANN ARBOR, Mich., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V: ZOM ) (“Zomedica” or “Company”), a veterinary pharmaceutical and diagnostic company, today announced a [...]
Repros Therapeutics Inc.® Announces Acquisition by Allergan plc
12/12/2017
THE WOODLANDS, Texas, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc. (NASDAQ: RPRX ) (“Repros” or the “Company”) today announced that it has entered into a definitive agreement under which Allergan plc (“ [...]
Pluristem Granted Manufacturer Authorization and Good Manufacturing Practice (GMP) Certification by Israel’s Ministry of Health, Supporting Pivotal-Stage Studies
12/12/2017
Authorization is also under the provision of the Conformity Assessment and Acceptance of Industrial Products (CAA) agreement between Israel and the European Union (EU), which will serve to qualify Pluristem’s facilities [...]
Transactions in relation to share buyback program
12/12/2017
Acting under its share buyback authorization, the GN Store Nord board of directors initiated a share buyback program on May 4, 2017 in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
Genetic Technologies Provides Update on Strategic Review Initiative
12/12/2017
MELBOURNE, Australia, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ: GENE ) (“ Company ”), a molecular diagnostics company focused on cancer risk assessment, and provider of BREVAGen [...]
PsiOxus Therapeutics Receives $15 Million Milestone Payment as Armed Oncolytic Virus Licensed to Bristol-Myers Squibb Achieves CTA
12/12/2017
OXFORD, United Kingdom, Dec. 12, 2017 (GLOBE NEWSWIRE) -- PsiOxus Therapeutics, Ltd. (PsiOxus) today announced that the Clinical Trial Application for NG-348, an “armed” oncolytic virus for the treatment of solid tumors [...]
Operational Update
12/12/2017
SYDNEY, Australia, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Immutep Limited (ASX:IMM) (NASDAQ: IMMP ) (Immutep or the Company), has provided an update on the Company’s two ongoing clinical trials with eftilagimod alpha (LAG- [...]
NEOVACS ANNOUNCES POSITIVE RESULTS OF PRECLINICAL STUDY FOR IFNalpha KINOID IN TYPE 1 DIABETES
12/12/2017
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS ANNOUNCES POSITIVE RESULTS OF PRECLINICAL STUDY FOR IFNalpha KINOID IN TYPE 1 DIABETES Company intends to continue preclinical development in this indication in 2018 [...]
NÉOVACS ANNONCE DES RÉSULTATS POSITIFS POUR SON ÉTUDE PRÉCLINIQUE AVEC l'IFNalpha KINOIDE DANS LE DIABÈTE DE TYPE 1
12/12/2017
COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE NÉOVACS ANNONCE DES RÉSULTATS POSITIFS POUR SON ÉTUDE PRÉCLINIQUE AVEC l'IFNalpha KINOIDE DANS LE DIABÈTE DE TYPE 1 La société poursuivra ce [...]
INNATE PHARMA : UPCOMING INVESTOR CONFERENCES
12/12/2017
upcoming investor conferences Marseille, France, December 12, 2017, 7:00 AM CET Innate Pharma SA (the "Company" - Euronext Paris: FR0010331421 - IPH) today announces that it will be present at the following investor [...]
INNATE PHARMA : PROCHAINS RENDEZ-VOUS INVESTISSEURS
12/12/2017
PROCHAINS RENDEZ-VOUS INVESTISSEURS Marseille, le 12 décembre 2018 Innate Pharma SA (Euronext Paris: FR0010331421 - IPH) annonce aujourd'hui qu'elle sera présente aux événements suivants au cours du premier trimestre [...]
Final Preclinical Asthma Study Confirms Efficacy
12/12/2017
Clear confirmation of efficacy of Cynata’s proprietary Cymerus™ MSCs in second preclinical asthma study Treatment with Cymerus MSCs in clinically-relevant model caused significantly greater reduction of airway [...]
Stephanie Finnegan joins Cromos™ Pharma as Chief Operating Officer, company looks to expand its North American footprint
12/12/2017
PORTLAND, Ore., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Cromos™ Pharma , a premier regional contract research organization announced today that Stephanie Finnegan has been appointed as its Chief Operating Officer. Ms. [...]
Editas Medicine Reports Data Supporting Multiple Approaches to Create Treatments for Sickle Cell Disease and Beta-Thalassemia
12/12/2017
CAMBRIDGE, Mass., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ: EDIT ), a leading genome editing company, today announced results from experiments to demonstrate expanded CRISPR genome editing [...]
GW Pharmaceuticals plc Announces the Closing of Public Offering of ADSs Raising Gross Proceeds of $317.4 Million and Full Exercise of Underwriter’s Option to Purchase Additional ADSs
11/12/2017
LONDON, Dec. 11, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH ) ("GW" or the “Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its [...]
Enzymotec Shareholders Approve Proposed Acquisition by Frutarom
11/12/2017
MIGDAL HA’EMEQ, Israel, Dec. 11, 2017 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (NASDAQ: ENZY ) (“Enzymotec” or the “Company”), a developer, manufacturer and marketer of innovative bio-active lipid ingredients and nutritional [...]
Scythian Biosciences Corp. Announces Appointment of Ottis Anderson to Pro Athlete Advisory Committee
11/12/2017
TORONTO, Dec. 11, 2017 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the " Company " or “ Scythian ”) (TSXV:SCYB) (Frankfurt: 9SB ) (OTC Pink:SCCYF) is pleased to announce that it has appointed Ottis Jerome “O.J.” [...]
Adaptimmune Data Presented at American Society of Hematology (ASH) Annual Meeting for NY ESO SPEAR T-cells in Multiple Myeloma Pilot Study
11/12/2017
PHILADELPHIA and OXFORD, United Kingdom, Dec. 11, 2017 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq: ADAP ), a leader in T-cell therapy to treat cancer, submitted updated data from its completed pilot study [...]
Karmanos Cancer Institute’s 24th Annual Partners Night continues to drive the future of cancer research
11/12/2017
DETROIT, Dec. 11, 2017 (GLOBE NEWSWIRE) -- When dedicated community members, including those touched by cancer, come together to support cancer research at Karmanos, it’s another way of describing the Barbara Ann [...]

Pages